Anissa Abi-Dargham, MD
Columbia University & New York Psychiatric Institute
Anissa Abi-Dargham, MD, is director of the Division of Translational Imaging at Columbia University. She uses Positron Emission Tomography imaging to study the neurobiology of schizophrenia and addiction. Her research has resulted in seminal findings describing complex topographically specific alterations of dopamine transmission in schizophrenia and their relationship to clinical symptoms, cognition and response to treatment. More recently she has expanded the work in her Division into multimodal imaging by building a multidisciplinary team with expertise in neurocomputational and neurocognitive disciplines. She is Associate Editor for Neuropsychopharmacology and Biological Psychiatry, President-Elect for ACNP and a member of the NIMH Board of Scientific Counselors.
Susan Bookheimer holds the Joaquin Fuster Endowed Chair in Cognitive Neuroscience in the Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine. She directs the Staglin Center for Cognitive Neurosciences as well as the Intellectual and Developmental Disabilities Research Center at UCLA. Dr. Bookheimer is a clinical neuropsychologist whose research methods include structural and functional MRI, PET, electrocortical stimulation mapping, and traditional neuropsychological approaches, focusing on language and memory in development, aging, and neuropsychiatric disorders. She is past Chair of OHBM (2012-2013), Meetings Liaison (2003-2004), and headed the Local Organizing Committee for the OHBM 2009 meeting in San Francisco.
Fernando Lopes da Silva, MD, PhD, full professor of Physiology at Amsterdam University, and scientific director of the Dutch Institute of Epilepsy. He is now Emeritus Professor in Amsterdam and invited professor at Lisbon University. He is member of Academy of Sciences of The Netherlands. He has received several honorary distinctions, His main scientific interests are the study of brain physiology in general and of epilepsy in particular.
David Poeppel is the Director of the Department of Neuroscience at the Max-Planck-Institute (MPIEA) in Frankfurt, Germany, and a Professor of Psychology and Neural Science at NYU. Trained at MIT (cognitive science, linguistics, neuroscience), Poeppel did a post-doc at UCSF and until 2008 worked at the University of Maryland.
Dr. Seeley is a behavioral neurologist and neuroscientist at the University of California, San Francisco, where he is an Associate Professor of Neurology and Pathology and Director of the Neurodegenerative Disease Brain Bank. Dr. Seeley and his coworkers investigate the anatomical onset and progression of neurodegenerative disease. Their current research blends neuroanatomy, brain mapping, and neuropathology with molecular-genetic analyses, with the goals of clarifying selective vulnerability mechanisms and accelerating drug discovery by developing network-based neuroimaging biomarkers for monitoring disease progression. His work has focused on the behavioral variant of frontotemporal dementia, a clinical syndrome that helped identify the “salience network”, a system anchored by cortical hubs in the anterior cingulate and anterior insular cortices. Dr. Seeley’s work was recognized in 2011 with a Fellowship from the John D. and Catherine T. MacArthur Foundation.
National Institute on Drug Abuse
Dr. Volkow is Director of the National Institute on Drug Abuse at NIH. She pioneered the use of brain imaging to investigate the effects of drugs in the human brain and has demonstrated that drug addiction is a brain disease. She has published more than 600 scientific articles and edited three books. She has received multiple awards, including membership in the Institute of Medicine, named one of Time Magazine's "Top 100 People Who Shape our World", included as “One of the 20 People to Watch” by Newsweek magazine and named "Innovator of the Year" by U.S. News & World Report.
Royal Society Research Professor & Professor of Engineering Department of Engineering, University of Cambridge
Daniel Wolpert read medicine at Cambridge before completing an Oxford Physiology DPhil followed by a postdoctoral fellowship at MIT. He then joined the faculty at the Institute of Neurology, UCL and in 2005 moved to the Cambridge University where he is Professor of Engineering and a Royal Society Research Professor.